Prescribing practice with cognition enhancers in outpatient care: are there differences regarding type of dementia?--Results of a representative survey in lower Saxony, Germany.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Pharmacopsychiatry

• Publication date

  2007-04-23

• Fields of study

  Medicine

• Identifiers
  DOI 10.1055/S-2007-979562PMID 8858714
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Factors influencing the prescribing of nootropic drugs. Results of a representative inquiry in Lower Saxony].

  2008cited by this paper
• Diagnosis of dementia in primary care: results of a representative survey in Lower Saxony, Germany

  2005cited by this paper
• Cognitive effects of l-deprenyl in Alzheimer's disease

  2004cited by this paper
• [Ambulatory treatment of sleep disorders in the aged].

  1994cited by this paper
• Long‐term and high‐dose piracetam treatment of Alzheimer's disease

  1993cited by this paper
• Mental deterioration in old age: results of two multicenter, clinical trials with nimodipine. The Nimodipine Study Group.

  1993cited by this paper
• Vascular dementia

  1993cited by this paper
• A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study Group.

  1992cited by this paper
• The blood-brain barrier and cerebral microcirculation in Alzheimer disease.

  1992cited by this paper
• Dihydroergocryptine in the management of senile psycho-organic syndrome.

  1992cited by this paper
• Pentoxifylline in Cerebrovascular Dementia

  1992cited by this paper
• A controlled trial of tacrine in Alzheimer's disease. The Tacrine Study Group.

  1992cited by this paper
• [Dihydroergocristine in the treatment of organic brain psychosyndrome. Dose-finding study against placebo].

  1992cited by this paper
• Ginkgo biloba.

  1992cited by this paper
• Therapeutic efficacy of pyritinol in patients with senile dementia of the Alzheimer type (SDAT) and multi-infarct dementia (MID).

  1992cited by this paper
• A written case simulation of osteoarthritis as a predictor of prescribing behavior among family practitioners

  1992cited by this paper
• Calcium channel blocker nimodipine for primary degenerative dementia.

  1991cited by this paper
• Does competence of general practitioners predict their performance? Comparison between examination setting and actual practice.

  1991cited by this paper
• [Therapy of organic brain syndrome with nicergoline given once a day].

  1991cited by this paper
• Effects of a MAO-B inhibitor in the treatment of Alzheimer disease.

  1991cited by this paper
• The therapeutic approaches of community based primary care practitioners to osteoarthritis of the hip in an elderly patient.

  1991cited by this paper
• Estimated prevalence of Alzheimer's disease in the United States.

  1990cited by this paper
• Tacrine (tetrahydroaminoacridine; THA) and lecithin in senile dementia of the Alzheimer type: a multicentre trial. Groupe Français d'Etude de la Tetrahydroaminoacridine.

  1990cited by this paper
• Naftidrofuryl in the Treatment of Mild Senile Dementia

  1990cited by this paper
• The validity of 3 clinical diagnostic criteria for Alzheimer's disease

  1990cited by this paper
• Written case simulations: do they predict physicians' behavior?

  1990cited by this paper
• Nimodipine in the treatment of old age dementias.

  1990cited by this paper
• Pharmacological Treatment Strategies in Dementia Disorders

  1989cited by this paper
• Diagnosis of dementia

  1989cited by this paper
• Randomized Clinical Trial of Daily Aspirin Therapy in Multi‐Infarct Dementia

  1989cited by this paper
• Effects of intravenous high dose co-dergocrine mesylate ('Hydergine') in elderly patients with severe multi-infarct dementia: a double-blind, placebo-controlled trial.

  1989cited by this paper
• Superoxide anion scavenging effect and superoxide dismutase activity ofGinkgo biloba extract

  1989cited by this paper
• Management of drug therapy in the elderly.

  1989cited by this paper
• Drug Treatments of Dementia

  1989cited by this paper
• The Families of Cognition Enhancers

  1989cited by this paper
• Effect of Piracetam on Cerebral Glucose Metabolism in Alzheimer's Disease as Measured by Positron Emission Tomography

  1988cited by this paper
• Prescribing for the Elderly Part I: Sensitivity of the Elderly to Adverse Drug Reactions *

  1988cited by this paper
• The NINCDS‐ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's disease

  1988cited by this paper
• Accuracy of the clinical diagnosis of vascular dementia: a prospective clinical and post-mortem neuropathological study.

  1988cited by this paper
• [Therapy of multi-infarct dementia with nicergoline: double-blind, clinical, psychometric and EEG imaging studies with 2 dosage schedules].

  1987cited by this paper
• A Controlled Double‐Blind Study of High‐Dose Dihydroergotoxine Mesylate (HydergineR) in Mild Dementia

  1987cited by this paper
• Binswanger's disease: a review.

  1987cited by this paper
• Cerebral amyloid angiopathy. A critical review.

  1987cited by this paper
• Improved cognition after control of risk factors for multi-infarct dementia.

  1986cited by this paper
• Useless drugs are not placebos: lessons from flunarizine and cinnarizine.

  1986cited by this paper
• Haemorheological pattern in initial mental deterioration: results of a long-term study using piracetam and pentoxifylline.

  1985cited by this paper
• Comparative randomized study of cerebral blood flow after long-term administration of pentoxifylline and co-dergocrine mesylate in patients with chronic cerebrovascular disease.

  1985cited by this paper
• Memory Dysfunction and Vigilance: Neurophysiological and Psychopharmacological Aspects

  1985cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1984cited by this paper
• Pathological verification of ischemic score in differentiation of dementias

  1980cited by this paper
• [Sociopharmacology--psychoactive drugs as an example].

  1979cited by this paper
• Cerebral blood flow in dementia.

  1975cited by this paper

• Exploring the Remarkable Potential of Algal Biomass for the Production of Nutraceutical Compounds and Their Applications

  2024cites this paper
• Therapeutic Potential and Nutraceutical Profiling of North Bornean Seaweeds: A Review

  2022cites this paper
• Popular Herbal and Natural Remedies Used in Psychiatry.

  2018cites this paper
• Prevention strategies for Alzheimer’s disease

  2012cites this paper
• Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's disease.

  2012cites this paper
• Neuropharmacological Properties of Marine Plants

  2012cites this paper
• Neuroprotective effect of seaweeds inhabiting South Indian coastal area (Hare Island, Gulf of Mannar Marine Biosphere Reserve): Cholinesterase inhibitory effect of Hypnea valentiae and Ulva reticulata.

  2010cites this paper
• Cholinesterase inhibitory effects of Rhizophora lamarckii, Avicennia officinalis, Sesuvium portulacastrum and Suaeda monica: Mangroves inhabiting an Indian coastal area (Vellar Estuary)

  2009cites this paper
• Cholinesterase inhibitors from Sargassum and Gracilaria gracilis: Seaweeds inhabiting South Indian coastal areas (Hare Island, Gulf of Mannar)

  2009cites this paper
• Diagnosis of Dementia in Primary Care: A Representative Survey of Family Physicians and Neuropsychiatrists in Germany

  2007cites this paper
• Terpene trilactones from Gingko biloba: from ancient times to the 21st century.

  2005cites this paper
• Review about Ginkgo biloba special extract EGb 761 (Ginkgo).

  2003cites this paper
• Pharmacological Treatment Strategies of Residential Primary Care Providers in Dementia Diseases - Results of a Representative Survey in Western Austria

  2002cites this paper
• Chronic aspirin ingestion improves spatial learning in adult and aged rats.

  2002cites this paper
• Polypharmacy of Alternative and Herbal Medications

  2002cites this paper
• Chronic daily administration of selegiline and EGb 761 increases brain's resistance to ischemia in mice.

  2001cites this paper
• Effect of the herbal extract combination Panax quinquefolium and Ginkgo biloba on attention-deficit hyperactivity disorder: a pilot study.

  2001influential citation
• Gender differences in the recognition of depression in old age.

  1999cites this paper
• Ginkgo biloba and Memory: An Overview.

  1998cites this paper
• Nonformulary drug requests at an academic hospital in Germany – the role of general practitioners' long-term medication

  1998cites this paper